- Management of viral hepatitis in liver transplant recipients
-
Jeong SW, Choi Y, Kim JW
- KMID: 2070250
- Clin Mol Hepatol.
- 2014 Dec;20(4):338-344.
- doi: 10.3350/cmh.2014.20.4.338
Recurrence of viral hepatitis after liver transplantation (LT) can progress to graft failure and lead to a decrease in long-term survival. Recently, there have been remarkable improvement in the treatment... -
- CITED
-
- Close
- SHARE
-
- Close
- Clinical Implications of Chemokines in Acute and Chronic Hepatitis C Virus Infection
-
Kang W, Shin EC
- KMID: 1058805
- Yonsei Med J.
- 2011 Nov;52(6):871-878.
- doi: 10.3349/ymj.2011.52.6.871
Hepatitis C virus (HCV), a non-cytopathic positive-stranded RNA virus, is one of the most common causes of chronic liver diseases such as chronic hepatitis, liver cirrhosis and hepatocellular carcinoma. Upon... -
- CITED
-
- Close
- SHARE
-
- Close
- Monitoring antibody titers to recombinant Core-NS3 fusion polypeptide is useful for evaluating hepatitis C virus infection and responses to interferon-alpha therapy
-
Park YM, Byun BH, Choi JY, Bae SH, Kim BS, So HS, Ryu WS
- KMID: 648075
- J Korean Med Sci.
- 1999 Apr;14(2):165-170.
- doi: 10.3346/jkms.1999.14.2.165
To evaluate the clinical feasibility of the antibody titer against a chimeric polypeptide (named Core 518), in which a domain of Core and NS3 of hepatitis C virus (HCV) was... -
- CITED
-
- Close
- SHARE
-
- Close
- Clinical applications of transient elastography
-
Jung KS, Kim SU
- KMID: 1743723
- Clin Mol Hepatol.
- 2012 Jun;18(2):163-173.
- doi: 10.3350/cmh.2012.18.2.163
Chronic liver disease represents a major public health problem, accounting for significant morbidity and mortality worldwide. As prognosis and management depend mainly on the amount and progression of liver fibrosis,... -
- CITED
-
- Close
- SHARE
-
- Close
- The prediction of interferon-alpha therapeutic effect by sequence variation of the HCV hypervariable region 1
-
Yeh BI, Kim HW, Kim HS, Lee JY, Lee KH, Lee KM, Kim JS, Han KH
- KMID: 711674
- Yonsei Med J.
- 1999 Oct;40(5):430-438.
- doi: 10.3349/ymj.1999.40.5.430
Interferon-alpha (IFN-alpha) has been used to treat hepatitis C virus (HCV)-induced hepatitis, but it has been effective in only about half of the treated patients, with recurrence appearing in the... -
- CITED
-
- Close
- SHARE
-
- Close
- Immunosuppression status of liver transplant recipients with hepatitis C affects biopsy-proven acute rejection
-
Kim JM, Lee KW, Song GW, Jung BH, Lee HW, Yi NJ, Kwon CD, Hwang S, Suh KS, Joh JW, Lee SK, Lee SG
- KMID: 2373137
- Clin Mol Hepatol.
- 2016 Sep;22(3):366-371.
- doi: 10.3350/cmh.2016.0022
BACKGROUND/AIMS: The relationship between patient survival and biopsy-proven acute rejection (BPAR) in liver transplant recipients with hepatitis C remains unclear. The aims of this study were to compare the characteristics... -
- CITED
-
- Close
- SHARE
-
- Close
